Clinical Trial Update: Efficacy and Safety of NicVAX® Co-administered With Varenicline (Champix®) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of NicVAX co-administered with varenicline for smoking cessation; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• Champix (varenicline)
• NicVAX (nicotine vaccine)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Smoking Behavior, Smoking Lapse Behavior | Phase 2 | Status: COMPLETED